Together, these results show that GILZ can be expressed by neutrophils during the course of ARDS, at both the protein and gene level, and that its expression level is associated with clinical severity, more specifically than other markers of inflammation or its resolution. This evidence concerns the gene TSC22D3 and acute respiratory distress syndrome.